Search results
Results from the WOW.Com Content Network
Montelukast (Singulair) is a drug that relieves allergy symptoms and prevents asthma attacks. It eases nose congestion and cuts down on sneezing, itching, and eye allergies. For people with ...
Leukotriene modifiers include two types of agents: Leukotriene synthesis inhibitors, such as zileuton, block the enzyme, 5-lipoxygenase, which is necessary for the formation of leukotrienes. Montelukast, zafirlukast, and zileuton may be considered for the treatment of asthma.
Leukotriene modifiers, also called leukotriene receptor antagonists, are a group of medications. They can help prevent breathing problems associated with allergies, asthma and chronic obstructive pulmonary disease. Examples include montelukast, zafirlukast and zileuton.
Montelukast and zafirlukast are cysteinyl leukotriene receptor antagonists indicated to prevent and treat chronic asthma. Leukotrienes are eicosanoid inflammatory mediators derived from arachidonic acid.
An antileukotriene, also known as leukotriene modifier and leukotriene receptor antagonist, is a medication which functions as a leukotriene-related enzyme inhibitor (arachidonate 5-lipoxygenase) or leukotriene receptor antagonist (cysteinyl leukotriene receptors) and consequently opposes the function of these inflammatory mediators ...
Singulair is a leukotriene (loo-koe-TRY-een) inhibitor. Leukotrienes are chemicals your body releases when you breathe in an allergen (such as pollen). These chemicals cause swelling in your lungs and tightening of the muscles around your airways, which can result in asthma symptoms.
Leukotriene inhibitors are the first new class of medications for the treatment of persistent asthma that have been approved by the U.S. Food and Drug Administration in more than...
This topic reviews the biology of the leukotrienes, their role in asthma and inflammation, and the use of 5-lipoxygenase (5-LO) inhibitors and cysteinyl leukotriene (CysLT) receptor antagonists as treatments for asthma, rhinitis, and other allergic diseases.
Leukotriene modifiers help treat asthma symptoms by altering the action of leukotrienes, molecules that play a role in airway inflammation and constriction. Learn more.
Both leukotriene synthesis inhibitors and cysteinyl-leukotriene receptor antagonists have recently been shown to protect asthmatic patients against asthma attacks, but they are not useful as “rescue remedies” once an attack has already started.